Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | CFTR | P13569 | 1/20 | 0.34 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | GSK3A | P49840 | 2/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL317588 | 1.00 | MMP2 (0.44) | MMP2MMP9HTR2AMEN1KMT2A | |
| SCHEMBL3284760 | 0.80 | MMP2 (0.54) | MMP2MMP9MEN1KMT2ACYP1A2 | |
| SCHEMBL24524512 | 0.77 | LMNA (0.44) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL5740020 | 0.76 | HTR2A (0.48) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL7117159 | 0.75 | HTR2A (0.38) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL6070424 | 0.73 | ALDH1A1 (0.43) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL15490742 | 0.70 | HTR2A (0.43) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL2627033 | 0.68 | CYP1A2 (0.46) | HTR2AKMT2ACYP1A2ALDH1A1CYP2A6 | |
| SCHEMBL12409767 | 0.68 | HTR2A (0.40) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL15490617 | 0.68 | HTR2A (0.40) | HTR2AMEN1KMT2ACYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2045014-B1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | UNIV HOKKAIDO NAT UNIV CORP (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-8092720-B2 | Polymer-supported metal complex catalyst | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-09-10 | — | — | US | disclosed |
| EP-2045014-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | National University Corporation Hokkaido University (JP) | 2009-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | PYM1, ARG1, SCO2 | MMP2 3795/4885MMP9 3831/4885HTR2A 4459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.